ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium triacetoxyborohydride → 1,1-dimethylethyl ((3R,4S)-3-hydroxy-1-{2-[7-(methyloxy)-2-oxo-1,5-naphthyridin-1(2H)-yl]ethyl}-4-piperidinyl)carbamate

HRID 656977
印刷

反応式

HRID 656977 の反応式
CO[CH:3](O)[CH2:4][N:5]1[C:14]2[C:9](=[N:10][CH:11]=[C:12]([O:15][CH3:16])[CH:13]=2)[CH:8]=[CH:7][C:6]1=[O:17].CC(N([C@H]1CCNC[C@H]1O)C(=O)[O-])(C)C.[C:34]([O:38][C:39](=[O:48])[NH:40][C@H:41]1[CH2:46][CH2:45][NH:44][CH2:43][C@H:42]1[OH:47])([CH3:37])([CH3:36])[CH3:35].C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>C(Cl)(Cl)Cl.CO>[OH:47][C@H:42]1[C@@H:41]([NH:40][C:39](=[O:48])[O:38][C:34]([CH3:36])([CH3:35])[CH3:37])[CH2:46][CH2:45][N:44]([CH2:3][CH2:4][N:5]2[C:14]3[C:9](=[N:10][CH:11]=[C:12]([O:15][CH3:16])[CH:13]=3)[CH:8]=[CH:7][C:6]2=[O:17])[CH2:43]1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 5049666Sodium triacetoxyborohydrideHCID 67426921tert-butyl N-[(3R,4S)-3-hydroxypiperidin-4-yl]carbamateHCID 866230711,1-dimethylethyl[(3R,4S)-3-hydroxy-4-piperidinyl]carbamateHCID 86635329[7-(methoxy)-2-oxo-1,5-naphthyridin-1(2H)-yl]acetaldehyde methyl hemiacetal

生成物 1

HCID 58579448
1,1-dimethylethyl ((3R,4S)-3-hydroxy-1-{2-[7-(methyloxy)-2-oxo-1,5-naphthyridin-1(2H)-yl]ethyl}-4-piperidinyl)carbamate

試薬・触媒・溶媒 2

HCID 887Methanol溶媒HCID 6212Chloroform溶媒

実験手順

[7-(methoxy)-2-oxo-1,5-naphthyridin-1(2H)-yl]acetaldehyde methyl hemiacetal (200 mg, 0.7992 mmol) and 1,1-dimethylethyl[(3R,4S)-3-hydroxy-4-piperidinyl]carbamate (for a synthesis see WO2004058144, Example 5(c), cis-(3-hydroxy-piperidin-4-yl)-carbamic acid tert-butyl ester Enantiomer 1) (173 mg, 1 eq.) were stirred in chloroform (10 ml) plus MeOH (0.5 ml) under argon for 2 h. Sodium triacetoxyborohydride (508 mg, 3 eq.) was added in one portion and the mixture was stirred at rt over the weekend, then quenched by addition of saturated aqueous sodium hydrogen cabonate (20 ml) and extracted with 20% v:v MeOH in DCM (3×200 ml). The organic extractes were combined, dried over anhydrous magnesium sulphate, filtered and evaporated under reduced pressure to give the crude product, which was purified by column chromatography on silica, eluted with 0-20% (2M ammonia in MeOH) in DCM. Appropriate fractions were combined and evaporated under reduced pressure to give 1,1-dimethylethyl ((3R,4S)-3-hydroxy-1-{2-[7-(methyloxy)-2-oxo-1,5-naphthyridin-1(2H)-yl]ethyl}-4-piperidinyl)carbamate (263 mg) as an off-white foam.

後処理

  1. customquenched by addition of saturated aqueous sodium hydrogen cabonate (20 ml)
  2. extractionextracted with 20% v
  3. dry with materialdried over anhydrous magnesium sulphate
  4. filtrationfiltered
  5. customevaporated under reduced pressure
  6. customto give the crude product, which
  7. customwas purified by column chromatography on silica
  8. washeluted with 0-20% (2M ammonia in MeOH) in DCM
  9. customevaporated under reduced pressure

出典と根拠

ORDレコード
ord-0427942d2d8944f1be03d17a2917ec64
出典データセット
uspto-grants-2011_12
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08071592B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート